PAH and phenylketonuria: Gene editing tools such as CRISPR/Cas9 offer a means of permanently correcting mutated Pah. Indeed, studies conducted in PKU-deficient mice showed a sustained reduction in Phe levels (Richards et al., 2020; Böck et al., 2022).